Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aftolimor is a veterinary vaccine developed and manufactured by LIMOR (Laboratorios Limor de Colombia) for the prevention and control of foot-and-mouth disease (FMD) in cattle. It is an inactivated viral vaccine designed to elicit a protective immune response against the Foot-and-Mouth Disease Virus (FMDV), specifically targeting serotypes common in the Andean region, such as serotypes O and A. The vaccine is typically administered as part of mandatory national vaccination campaigns to maintain FMD-free status in livestock populations. It is formulated with an oil-based adjuvant to enhance immunogenicity and provide sustained protection. Aftolimor is a critical component of the livestock health infrastructure in Colombia, where it is used to protect cattle from the highly contagious FMDV, which can have significant economic impacts on the agricultural sector.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aftolimor.